Genscript Biotech Co. (OTCMKTS:GNNSF – Get Free Report)’s stock price was down 3.9% during mid-day trading on Friday . The stock traded as low as C$1.22 and last traded at C$1.22. Approximately 1,500 shares changed hands during trading, a decline of 97% from the average daily volume of 49,468 shares. The stock had previously closed at C$1.27.
Genscript Biotech Stock Performance
The firm has a 50-day moving average of C$1.29 and a 200-day moving average of C$1.40.
About Genscript Biotech
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.
Recommended Stories
- Five stocks we like better than Genscript Biotech
- Why Invest in High-Yield Dividend Stocks?
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- Investing In Preferred Stock vs. Common Stock
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- 3 Stocks to Consider Buying in October
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Genscript Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genscript Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
